approval
saveQULIPTA (ATOGEPANT) — FDA approval
community read0 votes
Sponsor: ABBVIE. Form: TABLET. Route: ORAL
view source ↗Data sources
last refreshed 5mo ago
Found something off?
drug timeline · 5
- approvalQULIPTA (ATOGEPANT) — FDA approvalSep 30, 2025 · 370d ago
- approvalQULIPTA (ATOGEPANT) — FDA approvalJun 10, 2025 · 482d ago
- approvalQULIPTA (ATOGEPANT) — FDA approvalJun 10, 2025 · 482d ago
- approvalQULIPTA (ATOGEPANT) — FDA approvalMar 21, 2025 · 563d ago
- approvalQULIPTA (ATOGEPANT) — FDA approvalSep 28, 2021 · 1833d ago
same company · ±60 days · 6
- approvalupadacitinib tartrate ER: RINVOQ (UPADACITINIB) — FDA approvalApr 10, 2023
- approvalIMBRUVICA (IBRUTINIB) — FDA approvalMay 18, 2023
- approvalIMBRUVICA (IBRUTINIB) — FDA approvalMay 18, 2023
- approvalupadacitinib tartrate ER: RINVOQ (UPADACITINIB) — FDA approvalMay 18, 2023
- approvalORIAHNN (COPACKAGED): ORIAHNN (COPACKAGED) (ELAGOLIX SODIUM,ESTRADIOL,NORETHINDRONE ACETATE) — FDA approvalJun 5, 2023
- approvalelagolix sodium: ORILISSA (ELAGOLIX SODIUM) — FDA approvalJun 5, 2023
comments(0)
5-min edit window · permanent after that